NCT06703229

Brief Summary

The principal outcome assessed was the duration until the initial request for analgesia post-surgery. The secondary outcomes encompassed the total quantity of analgesics administered (ketorolac, paracetamol, and morphine) within the initial 24 hours. Pain levels, measured using the Visual Analogue Scale (VAS), were evaluated at rest and during movement at many intervals following surgery (1, 6, 12, and 24 hours). The study also observed postoperative complications, such as emesis, hypotension, bradycardia, and pruritus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

November 21, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 25, 2024

Completed
Last Updated

December 10, 2024

Status Verified

November 1, 2024

Enrollment Period

10 months

First QC Date

November 21, 2024

Last Update Submit

December 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • the initial request for analgesia post-surgery

    The postoperative Visual Analogue Scale (VAS) is a 10 cm horizontal line labeled "no pain" at one end and "worst pain" on the other end.

    24 hours

Study Arms (2)

group, D1

ACTIVE COMPARATOR

group, D1, had a TAP block that included 0.5 µg/kg of dexmedetomidine and bupivacaine

Drug: The Transversus Abdominis Plane (TAP) block

group, D2

ACTIVE COMPARATOR

group, D2, received the same block but with 1 µg/kg of dexmedetomidine.

Drug: The transverse abdominis plane (TAP) block

Interventions

or injectate preparation, utilizing ultrasound guidance while the patient was supine. In the D1 group, patients were administered 20 mL of 0.25% isobaric bupivacaine with 0.5 mcg/kg of dexmedetomidine.

group, D1

Patients in the D2 group received 20 mL of 0.25% isobaric bupivacaine with 1 mcg/kg of dexmedetomidine.

group, D2

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • with ASA physical status I or II
  • scheduled for elective unilateral inguinal hernioplasty under spinal anesthesia
  • aged 18 to 60 years
  • both genders

You may not qualify if:

  • patient refusal, BMI ≥ 40 kg/m2 incapacity to engage in pain assessment contraindications to spinal anesthesia (e.g., coagulopathy, skin infection)
  • \- and intolerance to the research medications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Egyptian liver hospital

Al Mansurah, Ansoura, 42526, Egypt

Location

MeSH Terms

Interventions

Dental Occlusion

Intervention Hierarchy (Ancestors)

DentistryDental Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia, Surgical Intensive Care and Pain Management, Faculty of Medicine, Port Said University

Study Record Dates

First Submitted

November 21, 2024

First Posted

November 25, 2024

Study Start

January 15, 2024

Primary Completion

November 15, 2024

Study Completion

November 15, 2024

Last Updated

December 10, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations